Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD8 is down(regulated) for tolerance.
Rodríguez-Rodríguez N, Rosetti F, Crispín JC. Rodríguez-Rodríguez N, et al. Among authors: rosetti f. Trends Immunol. 2024 Jun;45(6):442-453. doi: 10.1016/j.it.2024.04.012. Epub 2024 May 22. Trends Immunol. 2024. PMID: 38782625
Transient inhibition of sodium-glucose cotransporter 2 after ischemia/reperfusion injury ameliorates chronic kidney disease.
Martínez-Rojas MÁ, Balcázar H, González-Soria I, González-Rivera JM, Rodríguez-Vergara ME, Velazquez-Villegas LA, León-Contreras JC, Pérez-Villalva R, Correa F, Rosetti F, Bobadilla NA. Martínez-Rojas MÁ, et al. Among authors: rosetti f. JCI Insight. 2024 Feb 22;9(6):e173675. doi: 10.1172/jci.insight.173675. JCI Insight. 2024. PMID: 38516890 Free PMC article.
Sepsis Impairs IFN-γ Production in CD8 T Cells through Changes in Local Chromatin Landscape.
Cisneros-Segura JA, Rodríguez-Rodríguez N, Albarrán-Godínez A, García-González HB, Rodríguez-Osorio CA, Valdés-Ferrer SI, Tapia-Urzúa G, Recillas-Targa F, Madera-Salcedo IK, Rosetti F, Crispín JC. Cisneros-Segura JA, et al. Among authors: rosetti f. J Immunol. 2024 Sep 1;213(5):619-627. doi: 10.4049/jimmunol.2300772. J Immunol. 2024. PMID: 39037267
Down-Regulation-Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon-γ Production.
Madera-Salcedo IK, Ramírez-Sánchez AL, Rodríguez-Rodríguez N, García-Quintero R, Rubio RM, Morales-Montes de Oca G, Dávalos E, Cuervo R, Furuzawa-Carballeda J, Alcocer-Varela J, Gómez-Martín D, González-Yáñez M, de la Cruz A, Albarrán-Godínez A, Suárez-Rojas G, Romero-Díaz J, Uribe-Uribe NO, Alarcón-Riquelme M, Furlan-Magaril M, Mejía-Vilet JM, Crispín JC, Rosetti F. Madera-Salcedo IK, et al. Among authors: rosetti f. Arthritis Rheumatol. 2023 Jun;75(6):961-972. doi: 10.1002/art.42435. Epub 2023 Mar 22. Arthritis Rheumatol. 2023. PMID: 36575804
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
Piccirillo MC, Bonanno L, Garassino MC, Esposito G, Dazzi C, Cavanna L, Burgio MA, Rosetti F, Rizzato S, Morgillo F, Cinieri S, Veccia A, Papi M, Tonini G, Gebbia V, Ricciardi S, Pozzessere D, Ferro A, Proto C, Costanzo R, D'Arcangelo M, Proietto M, Gargiulo P, Di Liello R, Arenare L, De Marinis F, Crinò L, Ciardiello F, Normanno N, Gallo C, Perrone F, Gridelli C, Morabito A. Piccirillo MC, et al. Among authors: rosetti f. J Thorac Oncol. 2022 Sep;17(9):1086-1097. doi: 10.1016/j.jtho.2022.05.008. Epub 2022 Jun 1. J Thorac Oncol. 2022. PMID: 35659580 Free article. Clinical Trial.
71 results